Mark Rosenthal
0000-0003-1152-6764
Peter MacCallum Cancer Institute
3 papers found
Refreshing results…
Neuro-Oncology and Radiogenomics: Time to Integrate?
Buparlisib plus carboplatin or lomustine in patients with recurrent glioblastoma: a phase Ib/II, open-label, multicentre, randomised study
Phase I, open-label, multicentre study of buparlisib in combination with temozolomide or with concomitant radiation therapy and temozolomide in patients with newly diagnosed glioblastoma
Missing publications? Search for publications with a matching author name.